Key Statistics for BIOGB
|Current P/E Ratio (ttm)
Relative P/E vs.
|Earnings Per Share (SEK) (ttm)
|Est. EPS (SEK) (12/2013)
|Est. PEG Ratio
|Market Cap (M SEK)
|Shares Outstanding (M)
|30 Day Average Volume
|Dividend Indicated Gross Yield
|Cash Dividend (SEK)
|5 Year Dividend Growth
|Next Earnings Announcement
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for BIOGB
- Net Income (M/SEK)
BioGaia AB develops and markets health care products. The Company sells foods with healthy additives that help increase resistance against illnesses, and nutritional products with therapeutic effects for adults and children. BioGaia also sells animal feeds and performs pharmaceutical research in the United States and Sweden. Many products are sold worldwide by license.
More Company Profile & Key Executives for BIOGB
|Peter RothschildPresident/Founder||Margareta HagmanExec VP:Acctg & IR|
|Urban StrindlovExec VP:Partner & Product Dev||Eamonn ConnollySenior VP:Research|
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.